Wikidata

(Q64047066)

English

Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

clinical trial

In more languages

Statements

short name
CERTAIN (English)
0 references
title
A Phase IIIB, Multi-center, Double-blind, Placebo-controlled, Parallel Group, 52-week Study to Evaluate the Safety and Efficacy of Certolizumab Pegol, Administered With DMARDs, in Patients With Low to Moderate Disease Activity Rheumatoid Arthritis (English)
0 references
country
Austria
0 references
France
0 references
Germany
0 references
Italy
0 references
Poland
0 references
start time
June 2008
0 references
end time
May 2010
0 references
number of participants
194
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64047066&oldid=1857540455"